In a cohort of 4059 healthy volunteers (age range: 45-64 years) enrolled throughout the French metropolitan territory and followed between 1996 and 2001 (mean follow-up ¼ 5.470.3 years), the prevalence of hypertension at baseline (42.4% in men and 24.6% in women) and the percentage of hypertensive individuals taking antihypertensive medication (19.9% in men and 34.9% in women) were low compared to the figures observed in randomly selected individuals. Likewise, the percentages of controlled individuals among treated or hypertensive individuals (33.3 and 6.6% in men, and 62.3 and 21.8% in women) were high, as expected from lower exposure of volunteers to hypertension risk factors. However, the incidence of hypertension during follow-up (35.0% in men and 26.6% in women) was unexpectedly high compared to the figures observed in randomly selected individuals from other Caucasian populations.
The information describing the burden of hypertension in France in the last 15 years is dispersed with no data collected yet from a nationally representative population sample. Among the few available studies, the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) project that compiled data from 41 populations in 22 countries worldwide suggested that the prevalence, treatment and control of hypertension in middle-aged French adults were about average. 1 Data on the incidence of hypertension in the French population are even scarcer despite the fact that it is a critical parameter for assessing the impact of the disease independently of the mortality rate and demographic changes. In the last 15 years, only one study has been performed in subjects enrolled by occupational physicians in different workplaces between 1997 and 1999. 2 It has reported a very high incidence rate compared to those habitually seen in other Caucasian populations. To confirm this observation, the prevalence, treatment, control and incidence of hypertension were investigated in the late 1990s in a French cohort of middle-aged healthy volunteers.
The cohort was composed of volunteers of Caucasian origin (495%) who participated to the SU.VI.MAX trial, whose aim was to test whether adequate intake of antioxidants reduces the incidence of cancers and ischaemic cardiovascular diseases in middle-aged population. 3 They were enrolled throughout the metropolitan French territory in 1994 and 1995 and randomly allocated to receive either a combination of antioxidants at nutritional doses or a placebo for 8 years. Eligibility criteria included the absence of overt disease that could have hindered participation to the study or threatened survival. The present analysis was performed in all volunteers aged 45-64 years (n ¼ 4059) who attended a clinical visit in 1996 and 2001 (mean follow-up ¼ 5.470.3 years) among those initially enrolled in the SU.VI.MAX trial (n ¼ 12 741). The supplemented and placebo groups were merged as the antioxidant supplementation has been shown to have no effect on the risk of developing hypertension during the course of the trial. 4 At each clinical visit, blood pressure was taken once on each arm with a standard mercury sphygmomanometer and appropriate-sized cuff after 10 min of rest in a supine position. If the mean of the two readings was below 160 (systole) and 100 mm Hg (diastole), it was used for the analyses. Otherwise, blood pressure was measured again on each arm after 10 additional minutes of rest and the lowest mean was retained for the analyses. Participants also completed detailed questionnaires reporting medication intake, health event, consultation and hospitalization. 3 At baseline, the distributions of age, body mass index, region of residence and education level of the volunteers were significantly different (Po0.0001) from those observed in the French population (Supplementary Table 1 ). In both sexes, volunteers were younger, leaner, more educated and those living in the centre of the country were overrepresented compared to their nationally representative counterparts.
The prevalence, treatment, control and incidence of hypertension in the cohort are described in Table 1 , together with the rates reported by other studies in 45-to 64-year-old individuals selected from the French population or from other Caucasian populations during the 1990s. The comparison among the French population samples shows that the prevalence of hypertension and the percentage of hypertensive individuals taking antihypertensive medication were lower in healthy volunteers than in workers or randomly selected individuals, while the percentages of controlled individuals among treated or hypertensive individuals were higher. When considering only randomly selected individuals, the prevalence, treatment and control rates were similar in the French, Polish and Italian populations but very different from the figures observed in the North American population. In contrast, the incidence of hypertension in healthy French volunteers and workers was high compared to the rates observed in randomly selected individuals from other countries. Despite this high rate, the incidence of hypertension in the cohort showed the expected relationships with age, body mass index and blood pressure of participants at baseline (Supplementary Table 2 ).
The present study describes the prevalence, treatment, control and incidence of hypertension in a cohort of middle-aged healthy volunteers enrolled throughout the French metropolitan territory in the late 1990s. It shows that the incidence of hypertension was high in comparison to the rates reported in other Caucasian populations, thus confirming the findings of a previous study performed in French workers. 2 The high incidence of hypertension in the cohort was observed together with below average rates for the prevalence and treatment and above average rates for the control of hypertension.
Although it is obviously difficult to compare rates reported by different studies, a qualitative comparison was made by only considering the studies that used similar protocols, that is, same definition of hypertension, hypertensive status determined at a single visit by multiple readings of blood pressure after several minutes of rest, and use of a validated device by trained investigators. Such comparison confirms that the prevalence, treatment and control of hypertension in randomly selected French subjects were in the average of the figures reported in other European populations, as previously suggested by the MONICA project. 1 It also indicates that the French and European rates differed markedly from those observed in the United States. The higher percentages of treated or controlled individuals in the United States might be related to the more aggressive therapeutic approach that is pursued in this country. 11 However, it is more difficult to understand why the prevalence of hypertension would be lower in the United States, as the American population did not seem to be particularly protected from major risk factors for hypertension such as obesity. 11 The incidence of hypertension reported in French workers was very high compared to the figures observed in randomly selected individuals from other Caucasian populations, especially in men. The incidence of hypertension in French healthy volunteers, although lower than in workers, was also high compared to the figures reported in randomly selected individuals from other populations. These results corroborate previous data obtained in the 1970s suggesting that the incidence of hypertension in France was at the high end of the figures described in Caucasian populations. 12 In summary, the present analysis in a cohort of healthy volunteers confirms that the incidence of hypertension in middle-aged French population in the late 1990s was high compared to the rates observed in other Caucasian populations. It remains to be determined which factors could explain such a high incidence rate.
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